Bicycle Therapeutics’ (BCYC) Buy Rating Reiterated at HC Wainwright
Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $55.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 143.90% from the company’s previous close. Other research […]
More Stories
UL Solutions Inc. (NYSE:ULS) Short Interest Down 56.2% in October
UL Solutions Inc. (NYSE:ULS – Get Free Report) saw a significant drop in short interest in the month of October....
P10 Holdings Inc (PIOIQ) (OTCMKTS:PIOIQ) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?
P10 Holdings Inc (PIOIQ) (OTCMKTS:PIOIQ – Get Free Report)’s share price passed above its two hundred day moving average during...
Alexco Resource (NYSEAMERICAN:AXU) Stock Crosses Above 200-Day Moving Average – Here’s Why
Alexco Resource Corp. (NYSEAMERICAN:AXU – Get Free Report) (TSE:AXR) shares crossed above its 200-day moving average during trading on Monday...
BlackBerry (NYSE:BB) Rating Increased to Hold at StockNews.com
BlackBerry (NYSE:BB – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold”...
StockNews.com Downgrades Ultrapar Participações (NYSE:UGP) to Hold
Ultrapar Participações (NYSE:UGP – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in...
Repligen (NASDAQ:RGEN) Rating Increased to Hold at StockNews.com
Repligen (NASDAQ:RGEN – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold”...